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The ealeitonin/~-CGRP (CT/CGRP) gene is ¢¢topically expressed ina wide variety of neoplasia. We have investigated the molecular meehanisnts 
responsible for this eetopic expression in the human ¢¢11 line BEN, which is derived from a poorly differentiated squamous cell lung carcinoma. 
We show that a trans-aeting factor which represses expression of the CT/CGRP gen¢ in HeLa cells is absent or inactive in BEN ~11-~0 and have 
lcealised the represser binding site to a 53 bp fragmem 1500 bp upstream of the transcription start site. 
Calcitonin; CGRP; Transcription; Repression; Ectopic expr~sion 
I. INTRODUCTION 
The aberrant or eetopic expression of certain peptide 
hormones, a common occurrence in many forms of non- 
endocrine neoplasia [1], often results in adverse clinical 
syndromes [2]. Several theories have been proposed to 
explain ectopie expression, yet the molecular mecha- 
nisms underlying this aberrant gene expression remain 
unknown. The CT/CGRP gene is eetopically expressed 
in a wide variety of neoplasia, including carcinomas of 
the lung, breast, colon and pancreas, and leukaemias 
[3,4]. We have examined the regulation of CT/CGRP 
gene expression in the lung carcinoma cell line BEN, 
which is derived from a poorly differentiated sqaamous 
cell carcinoma which ectopically expresses the CT/ 
CGRP gene [5]. We have compared this with that in the 
cervical czreinoma cell line, HeLa, which does not ex- 
press this gene [6]. We report that repression of the gene 
in HeLa cells is mediated by a trans-aeting factor that 
is inactive in BEN cells. We have localised the represser 
binding site to a 53 bp fragment 1500 bp upstream of 
the transcription start site. 
2. MATERIALS AND METHODS 
2,1. Plasmids 
A series of plasmids (¢algeat 1-6) were constructed, containing 
regions of th~ 5' flanking reBion of the CT/CGRP gene placed up- 
stream of the bacterial ¢hloramphenieol aeetyl transferase (CAT) re- 
porter gene, as shown in Fig. 1~ CT/CGRP gene fragments were 
obtained from the cosmid genomic lone cos CTI [6], and inserted 
upstream of the CAT gene in the vectors Geat-a nd Geat-e [8]. The 
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3' end of the C'I'/CGRP insert was the same in each of the ealgeat 
plasmids and corresponded tothe Sfa NI site which lies 9 bp into exon 
i. pAJfi7 was constructed by iigation of a 946 bp KpnIlBgl]I fragment 
from ¢a!ge, at I lo lfp,~l/BamHI dig~tgd pGemBiue 4 (Promega). 
RCAT 1 was co:retracted by ligatiag a 53 bp HtndllllPstl fragment 
Iron: czlgcat 1 to HotdlIl/Psti digested Bleat 2 [9]. 
2.2. Cell fines 
BEN cells were cultured in g-MEM ~upplementgd with 10% FCS 
as previously described [10]. HeLa cells vcere grown in DMEM supple- 
mented with 10% FCS in the same way. 
2.3. Calcium phosphate ransfeettora' and CAT assays 
Ceils were plated out tile day before lransf~tion; BEN cells at 3 x 
106 ce11~60 mm Petri dish and HeLa cells at 7 x l0 s ¢¢11s/100 turn Petri 
dish. Cells were transfeeted according to the proeed.re of German 
[11], with 10 #g of plasnaid DNA, except where stated otherwise. The 
precipitate was lift on the cells for 14--i 8 h, the cells glycerol shocked 
(BEN ¢¢11s 120 s; HeLa cells 30 s) and fresh medium added. Cells were 
harvested 36-72 h later, lysed by 3 cycles of fr~e/thawing and as- 
sayed for protein using the BCA protein assay kit (Pierce; Rockford, 
IL). Extragts equalized for protein were then a~a2/ed for CAT activity 
[11]. In some experiments, ¢¢11s were co-transfected with 2.5 /Jg 
pRSVIue DNA and the extracts were assayed for laeiferaze activity 
[15] directed by pRSVIue, as well as for CAT agtivity. We found no 
evidence for any sigailicant dilTerenees in transfgction efficiency for 
different CAT constructs. 
3. RESULTS 
In order to investigate the promoter activity of the 
CT/CGRP gene in both BEN and HeLa cells, a series 
of plasmids were constructed as shown in Fig. I. Ini- 
tially, calgeat 1, 2, 3 and 4 were transfeeted into both 
BEN and HoLa ceils. Fig. 2A shows that in BEN cells 
1670 bp of 5' flanking sequence (calgcat 1) induced 30- 
fold greater levels of CAT expression when transfected 
into BEN cells than was observed with a fusion gene 
containing only 150 bp of CT/CGRP promoter (calgeat 
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Fig, 1, Representation f CT/CGRP promoter constructs. The 5' flanking region of the CT/CGRP gcnc is shown, Restriction enzyme sites used 
in the construction of the promoter plasmRts are indicated: (K=Kpnl; P=Patl; H=HindlIl; Bg--Bg/ll; M=MspI; B=BamHI; $=SfaN1). (A) 
Construction of the series of CT/CORP promoter-CAT fusion plasmids. The 3' end of the CT/CGRP promoter, and its fusion to the CAT coding 
sequences %vas identical in all plasmids (see Methods). (ra) 946 bp Kpnl/BgllI fragment of the CT/CCIRP promoter was ligated to pGemBlue 4 to 
form pAJS7. (C) 53 bp HindllI/P.~'tI fragment of the CT/CORP promoter was ligated into BLeat 2 to lbrm Rcat 1. 
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Fig. 2. Transient expression of ealgcat 1--4 in (A) BEN cells and (B) HeLa cells. Cells were transfccted by calcium phosphate precipitation, with 
10/zg plasmid DNA, and harvested 36 h after the precipitate was removed. Resultant CAT activity was determin~l in extracts equalised for protein. 
CAT activity was quantitatod by liquid scintillation counting of the thin.layer chromatography plates, and calculated as the percentage conversion 
of chloramphenicol t  its a~tyiated products, relative to that generated by calgcat 4 for each cell line. Values shown are the mean of triplicate 
determinations of duplicate xperiments ± $EM. 
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Fig, 3, Cotranffcction of increasing amounts of pAJS7 with ealgeat 
1 relieves the repression in HeLa cells, HeLa cells were transiently 
translated with 5/~8 of either calgcat 1 or calgeat 2, together with 
increasing amoum~ of pAJS 7, as indicated, Cells were harvested 48 
h after transfcction and the extracts assayed for CAT activity. The 
total amount of DNA transferred, 25 fig, was kept constant by the 
addition of carrier plasmid DNA, Data arc shown as mean ± SEM 
(n=3) from a reprcaentati/¢ experiment. 
calgcat 1. The ability of this fragment to lift repression 
strongly suggests that repression ismediated by a trans. 
acting factor. 
To localis¢ the putative represser binding site further, 
plasmids calgcat 5 and 6 were constructed (Fig. 1). Fig. 
4 shows the CAT activity resulting from the transfection 
of these constructs into BEN and HeLa coils. In both 
cell types, calgcat 6directs ahigher level of CAT expres- 
sion than calgcat 2, reflecting the presence between u- 
cl¢otides -1670 and -724 of positively acting elements, 
as previously reported [6]. In BEN coils, calgcat 5 di. 
rects expression of even greater levels of CAT than does 
calgcat 6. However, in HeLa coils, CAT expression 
from calgcat 5 is almost abolished. These data indicate 
that the 53 bp between ucleotides -1472 and - 1525 
(Fig. 5A) contain sequences which repress expression i
HeLa cells, but which positively regulate xpression i  
BEN cells. 
The 53 bp putative repressor binding site fragment 
was inserted upstream of an HSV-tk promoter in a 
chimaeric CAT construct and transfected into HcLa 
cells. Fig. 5 shows that transcription was not repress, d 
from the HSV tk promoter by the addition of this 53 bp 
fragment, relative to the activity of the parent vector, 
Bleat 2. Thus the putative 53 bp represser binding site 
is unable to repress transcription from a heterologous 
promoter. 
4). Constructs containing sequences from -724 (calgcat 
2) or -292 (calgcat 3) nucleotides upstream of the tran- 
scription start site both directed 5-f-fold greater expres- 
sion than the 150 bp construct. This indicates the exist- 
ence of multiple, eis-acting, positive regulatory se- 
quences in the upstream region of the CT/CGRP gene. 
In HeLa ceils, constructs  containing 292 (calgcat 3) and 
724 bp (calgcat 2) of upstream information also directed 
greater levels of CAT expression (approximately 15- 
fold) than the 150 bp construct (Fig. 2B). However, 
HeLa cells contrasted with BEN cells in that the pres- 
ence of sequences between -724 and -1670 did not 
further aise CAT levels, as in BEN cells, but reduced 
them by over 50%. These data indicate that sequences 
located between -724 and -1670 mediate repression of 
CT/CGRP promoter activity in HeLa cells, but not in 
BEN cells. 
To ascertain whether a trans.acting factor was in- 
volved in this repression, the 946 bp fragment between 
nucleotides -724 and -1670, was subcloncd into pGcm- 
Blue 4 to form pAJS 7 (Fig. 1). As shown in Fig. 3, 
transfection i to HeLa cells of increasing amounts of 
pAJS 7, together with a constant amount of calgcat l, 
was able to relieve the repression. A 7-fold excess of the 
946 bp fragment was sufficient o restore the level of 
CAT activity generated by calgcat 1 to that of calgcat 
2. However, tranffection of increasing amounts of pAJS 
7 had no significant effect on the CAT activity directed 
by calgcat 2, demonstrating that this effect is specific to 
4. DISCUSSION 
Our results indicate that there is a represser protein 
acting on the CT/CGRP promoter in HeLa cells, which 
binds to a site between 1472 and 1525 nuclvotidvs up- 
stream of the transcription start site. The action of this 
represser may contribute to the non-expression f the 
CT/CGRP gcnv in HoLe cells. We have shown that the 
represser protein is inactive in BEN cells, and that this 
may explain the ectopic expression of the CT/CGRP 
gene in these cells. 
The inability of the putative represser binding site to 
mediate represson of transcription from a heterologous 
promoter in HeLa cells suggests that repression may 
operate by interaction between the putative represser 
protein and other proteins which specifically bind to the 
CT/CGRP promoter region. Alternatively, the re- 
presser could act by preventing the binding of posi- 
tively-acting factors, which themselves act synergisti- 
cally with other proteins binding to the promoter e- 
gion. This would be analogous to the repression of the 
p-interferon gene, which is lifted upon viral infection 
[12]. Upon induction, the represser protein dissociates, 
allowing two positively-acting factors to interact with 
an adjacent region. Supporting the view that repression 
of the CT/CGRP gene may be mediated through a sim- 
ilar mechanism, is our finding that the 53 bp fragment, 
which mediates repression in HoLe cells, stimulates 
CAT activity in BEN ceils, which do not possess an 
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Fig. 7. Transient expression of ealgeat 1, 5, 6 and 2 in (A) BEN and (B) HeLa cells, Cells were transfected with 10/.tg plasmid DNA, and harvested 
72 h after transfection. Resultant CAT activity was determined in protein eqaalised extracts and is shown expressed relative to that of call+eat 2 
in each cell line for a representative experiment. 
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Fig. 5. The effect of insertion of the represser element upstream of a heteroloL+ous promoter in HeLa cells. (A) The 53 bp PsttlHindllI fragment 
was inserted upstream of the HSV-tk promoter in the plasmid Bleat 2, to fot'm plasmid Rcatl, A reprezenmtive autoradio~raph (B) and ~raph 
(C) of the resultant CAT activity after transfection of Rcat 1 and the parent vector Bleat 2 into HeLa cells is shown. Values shown are the 
mean + SEM of triplicate determinations i  this experiment, There is no significant difference in the CAT activities produced by either plasmid 
in HeLa ceils, 
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active repressor. This suggests that positively-acting 
factors could interact with this region when no re- 
pressor is present. 
We have previously shown that the CT/CGRP gene 
possesses a CpG island towards the 5' end of the gene 
that is unmethylated in all normal tissues [7]. The theory 
of CpG islands argues that their unmethylated status 
not only allows binding of transcription factors to the 
DNA without interference from methyl groups, but also 
leads to a more open chromatin structure so that the 
same factors can gain access more easily to the DNA 
[13]. Genes whose expression is tissue.specific and 
which possess CpG islands must therefore be actively 
repressed in non-expressing tissues. Such a mechanism 
has been shown to operate in the case of the retinol 
binding protein [14]. Our demonstration of repression 
of CT/CGRP promoter activity in HeLa cells provides 
a second example. 
This paper suggests a possible model to explain the 
¢ctopic expression of the CT/CGRP gene. In non-ex- 
pressing tissues, represented here by HeLa cells, the 
CT/CGRP gene is repressed through the action of a 
repressor protein which binds upstream of the tran- 
scription start site. In the process of neoplastic transfor- 
mation this repressor protein is lost or inactivated. Once 
the repressor is inactive the CT/CGRP gene may be 
ectopically expressed immediately, or it may require 
further activation by positively-acting factors. Thus 
derepression of the CT/CGRP gene may lead to its ec- 
topic expression in certain forms of neoplasia. 
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